A Jointventure of
 
  • Save job
  • Saved Jobs (0)
  • A | A | A
 
Max-Planck-Institut für demografische Forschung (MPIDR)
www.demogr.mpg.de Logo - Max-Planck-Institut für demografische Forschung

Job Announcement

Research Scientist / Post-doc Positions

The Max Planck Institute for Demographic Research (MPIDR) is recruiting 1-2 full-time post-doctoral research scientists to work in one of the following research groups: Population Health, Labor Demography, or Fertility and Well-Being. Please see www.demogr.mpg.de for descriptions of these research groups. The positions are initially for 3 years, with the possibility of an extension. Starting date is flexible, with latest start fall 2018.

The MPIDR is a leading institute in demographic research hosting a diverse range of research groups with interdisciplinary topics. The working language of the MPIDR is English. We offer a competitive salary (starting at approx. 50,000€ for new post-docs), an excellent research environment, and institutional support for conference attendance and continuous education.

Applicants should submit:

  • Letter of interest
  • CV with publication list
  • 1 writing sample
  • Contact information for 3 references
Please see http://www.demogr.mpg.de/go/apply-demography to upload your English-language application. Inquiries about the positions should be sent to apply-demography@demogr.mpg.de. Review of applications will begin on the 1st of October, 2017, and applications will be accepted on a rolling basis until the position is filled.

The Max Planck Society wishes to increase the share of women in areas where they are underrepresented and strongly encourages women to apply. The Max Planck Society is committed to employing more individuals with disabilities and especially encourages them to apply.

Closing date: 01.10.2017
Closing date: 1 October 2017 Published on academics.com on date 8 September 2017
In your application, please refer to academics.com

Selected jobs

in academia and industry
4 September 2017
Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg
4 September 2017
Max Planck Institute of Experimental Medicine